Item 9 Labs Adds Expertise To Strengthen Its Board Of Directors

Appoints Law Enforcement Veteran Joe DiSalvo and Chief Franchise Officer Mike Weinberger to Board of Directors

PR Newswire

PHOENIX, May 12, 2021 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (“Item 9 Labs” or the “Company”), a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products, announced today that law enforcement veteran Joe DiSalvo and the Company’s Chief Franchise Officer Mike Weinberger have been appointed to its Board of Directors.

DiSalvo’s appointment demonstrates the Company’s focus on strengthening its corporate governance through more independent directors.

A seasoned law enforcement officer, DiSalvo brings decades of experience in supporting cannabis legalization. He is currently serving his third term as Sheriff of the Pitkin County Sheriff’s Office, located in Aspen, Colorado, a position he has held since 2010. Upon approval of Amendment 64 in Colorado, which made it the first state to legalize retail sale of adult-use cannabis, he founded the Valley Marijuana Council (VMC) to ensure there was education, safe use as well as safe storage and sale of the new retail products. The VMC sponsored school education programs, enacted rules for dispensaries to follow in addition to the guidelines provided by the state and educated parents on juvenile drug use. The organization also created an extensive program for dispensary employees to ensure each customer was properly educated before purchasing cannabis in Aspen. The program had a significant impact on the successful rollout of legal cannabis in Aspen and continues to influence neighboring counties.

“The success of legal cannabis comes down to one thing, education,” said DiSalvo. “Item 9 Labs is a people-first company with extensive education and training programs for its retail teams and the dispensaries that sell their products. They’re setting the bar for what conscious cannabis companies should do.”

With the recent acquisition of OCG Inc., Weinberger, previously COO of OCG Inc. and named Item 9 Labs’ Chief Franchise Officer at completion of the transaction, also joins the Company’s board. Weinberger leads all franchise-related growth areas of Unity Rd., while overseeing day-to-day operations of the franchise. A culture creator and growth driver with around 20 years in franchising, his professional experience has been focused on growing emerging concepts into nationally recognized brands. He has been instilling his franchise knowledge into the cannabis space since 2018 and paved the path for bringing the franchise business model to cannabis, opening the doors to cannabis entrepreneurship through the Unity Rd. franchise opportunity. 

Previously, Weinberger was the CEO of Maui Wowi, a global coffee and smoothie franchise with more than 500 units, and led its successful sale to Kahala Brands. Upon acquisition, his role shifted to Brand President and VP of Franchise Development, overseeing Kahala Brands’ nontraditional portfolio and growth strategies.

Item 9 Labs CEO, Andrew Bowden, said, “Cannabis is still relatively ‘new’ to most. There’s a lot of teaching to do and best practices to be shared, which makes Joe and Mike’s unique perspectives valuable assets for our future growth.”


About Item 9 Labs Corp.

 
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

Media Contact:
Item 9 Labs
Jayne Levy, Director of Communications
Phone: 480-542-9421
Email: [email protected]

Inv
estor Contact:
Item 9 Labs
Phone: 800-403-1140
Email: [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/item-9-labs-adds-expertise-to-strengthen-its-board-of-directors-301289554.html

SOURCE Item 9 Labs Corp.

IIROC Trading Halt – STS

Canada NewsWire

VANCOUVER, BC, May 12, 2021 /CNW/ – The following issues have been halted by IIROC:

Company: South Star Mining Corp.

TSX-Venture Symbol: STS

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 7:51 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference On Gene And Cell Therapy

PR Newswire

LOS ANGELES, May 12, 2021 /PRNewswire/ — (NASDAQ: ENOB) –  A novel approach to HIV cell therapy developed by Dr. Serhat Gumrukçu (Dr. Serhat), Director of the Seraph Research Institute (SRI), and his team was presented yesterday as a new approach to treating HIV in humans. The research findings and developments were presented at the 2021 Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) to thousands of industry attendees.

“Our novel approach here offers some new insights to try and achieve this goal by applying immune-based strategies.”

The presentation profiled A 54-year-old man with human immunodeficiency virus (HIV), who was not completely suppressing the virus under antiretroviral therapy (ART). The patient showed promising results when treated with this new novel cell therapy approach.

“Great advances have been made in the treatment of many disease states including HIV, with immune-based therapies,” says Dr. Phillip Musikanth, HIV specialist and Medical Director of Seraph Medical. “We have yet to master eliminating HIV from the human host. Our novel approach here offers some new insights to try and achieve this goal by applying immune-based strategies.”

Working in collaboration with the Seraph Research Institute, and under the oversight of an independent Institutional Review Board (IRB), the patient was treated by Dr. Musikanth at SRI’s clinical site Seraph Medical. Dr. Musikanth used an adoptive cell therapy involving natural killer (NK) and gamma delta T-cells (gdT), collected from a healthy donor.

The treatment commenced with interrupting the patient’s antiretroviral medications and administering preliminary supportive medications to ready the body for the new cell therapy. This resulted in an expected initial rise in the level of HIV detected in the bloodstream.

Approximately three weeks after the new treatment commenced, the patient’s HIV levels began to decline. At the 100-day mark, his viral load was below the level of detection (<20 copies/ml). To this day, over one year from the start of the new cell therapy treatment, the patient continues to go without antiretroviral medications and his HIV levels have remained at or below the detectable level.

The idea of using alloreactive immune cells to effectively eliminate any undesirable targets, like cancer, was pioneered in 1986 by Dr. Shimon Slavin in Israel. He initially developed this immunotherapy to treat chemotherapy-resistant cancers. “Having worked on creating novel cell therapies for the past 5 decades, I think the treatment developed at the Seraph Research Institute has great potential to eliminate HIV- infected cells and educate the immune system to fight the virus in new ways,” says Dr. Slavin.

Seraph Research Institute is currently in the process of seeking regulatory approval to expand into clinical trials.                                                   

About Serhat Gumrukçu, MD, PhD

Dr. Serhat Gumrukçu (Dr. Serhat) is the Executive Director and Director of Translational Research at the Seraph Research Institute, based in Los Angeles. His current research on infectious diseases focuses on creating new approaches and mechanisms of actions in antiviral therapies through co-opting virus-specific components of viral replication machinery, on viruses including SARS-CoV-2, HIV, HBV, influenza and Ebola.

About Phillip Musikanth, MD


Dr. Phillip Musikanth
is the Medical Director at Seraph Medical, which works in partnership with the Seraph Research Institute in the care and treatment of patients with chronic or terminal diseases. Dr. Musikanth has been practicing medicine since 1986. He completed his residency in Internal Medicine at the USC Medical Center in LA County. His medical practice focuses on General Internal Medicine and HIV/AIDS.

About Seraph Research Institute


Seraph Research Institute
is a non-profit research institution, founded by Dr. Serhat, registered with the U.S. Department of Health and Human Services, that works to advance medical science in the areas of unmet need. The organization’s team of leading research scientists and medical experts work to answer the fundamental questions rooted in science – studying disease at every level from molecular to cellular – and physiology, from individual to population-based scales to create novel approaches to help patients with incurable diseases.

Cision View original content:http://www.prnewswire.com/news-releases/a-promising-approach-to-hiv-cell-therapy-with-exciting-preliminary-results-was-presented-recently-at-the-leading-conference-on-gene-and-cell-therapy-301289547.html

SOURCE Seraph Research Institute

Akoya to Report First Quarter 2021 Financial Results on May 18, 2021

MARLBOROUGH, Mass., May 12, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2021 after the market close on Tuesday, May 18, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (833) 562-0146 for domestic callers or (661) 567-1226 for international callers, followed by Conference ID: 7824008. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Investor Contact:

David Deuchler
Gilmartin Group LLC
[email protected]

Media Contact:

Michelle Linn
Bioscribe, Inc.
774-696-3803
[email protected]



VMware Board Names Raghu Raghuram as CEO

VMware Board Names Raghu Raghuram as CEO

Sumit Dhawan Appointed President, Zane Rowe to Continue as CFO

Announces Preliminary Q1 FY22 Results

PALO ALTO, Calif.–(BUSINESS WIRE)–
VMware (NYSE: VMW) today announced that its Board of Directors has appointed Rangarajan (Raghu) Raghuram as Chief Executive Officer and member of the Board of Directors, effective June 1, 2021. An industry veteran, Raghuram is a strategic business leader who currently holds the position of Executive Vice President and Chief Operating Officer, Products and Cloud Services at VMware.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210512005362/en/

Raghu Raghuram (Photo: Business Wire)

Raghu Raghuram (Photo: Business Wire)

“I am thrilled to have Raghu step into the role of CEO at VMware. Throughout his career, he has led with integrity and conviction, playing an instrumental role in the success of VMware,” commented Michael Dell, chairman of the VMware Board of Directors. “Raghu is now in position to architect VMware’s future, helping customers and partners accelerate their digital businesses in this multi-cloud world.”

Since joining VMware in 2003, Raghuram has helped steer the company’s strategic direction and its technology evolution throughout VMware’s rich history. He helped grow the core virtualization business, drove VMware’s software defined data center strategy, constructed and guided VMware’s cloud computing business and SaaS transformation efforts, played a pivotal role in the company’s M&A strategy, and has been key in driving partnerships with Dell Technologies, hyper-scalers and other strategic partners.

“VMware is uniquely poised to lead the multi-cloud computing era with an end-to-end software platform spanning clouds, the data center and the edge, helping to accelerate our customers’ digital transformations,” said Raghu Raghuram. “I am honored, humbled and excited to have been chosen to lead this company to a new phase of growth. We have enormous opportunity, we have the right solutions, the right team, and we will continue to execute with focus, passion, and agility.”

“After a thorough and thoughtful search, the Board concluded that Raghu is the best person to lead the company as CEO, because he embodies our innovative culture, represents our values, and has a clear vision for VMware’s future,” said Paul Sagan, VMware’s lead independent director. “We also want to thank Zane Rowe for his leadership as Interim CEO and the crucial role he plays continuing as CFO.”

VMware also announced that Sumit Dhawan has been named President, leading all go-to-market functions including Worldwide Sales, Worldwide Partner and Commercial Organization, Customer Experience and Success (CXS), Marketing, and Communications. With his broad experience building and scaling subscription businesses and his customer-centric orientation, Dhawan is ideally suited to take on leadership of these teams. Dhawan currently serves as Senior Vice President and Chief Customer Officer at VMware where he has helped design the business strategy for emerging multi-cloud and subscriptions offerings, transforming how VMware’s customers can consume VMware services.

Sanjay Poonen, currently Chief Operating Officer, Customer Operations, has made the personal decision to leave VMware after his 7 years at the company, most recently leading Customer Operations and prior to that leading End-User Computing. “On behalf of the Board and the company, we thank Sanjay for his many contributions to VMware and wish him well in his future endeavors,” commented Sagan.

“I extend my warm congratulations to Raghu on his promotion to CEO and know he will take the company to new heights,” commented Sanjay Poonen, Chief Operating Officer, Customer Operations, VMware. “I will be cheering on the company’s success, as I embark on my next adventure.”

Preliminary Results for Q1, Fiscal Year 2022

Revenue for the first quarter of fiscal 2022 is expected to be $2.994 billion, an increase of 9.5% from the first quarter of fiscal 2021.

The combination of Subscription and SaaS and license revenue is expected to be $1.387 billion, an increase of 12.5% from the first quarter of fiscal 2021.

GAAP operating margin for the first quarter is expected to be 18.7%, and non-GAAP operating margin is expected to be 30.8%.

GAAP net income per diluted share is expected to be $1.01 per diluted share, and non-GAAP net income per diluted share is expected to be $1.76 per diluted share.

Additional details regarding VMware’s first quarter financial results will be announced after market close on Thursday, May 27, 2021. The company will host a conference call at 1:30 p.m. PT/ 4:30 p.m. ET that day to review financial results and business outlook. A live web broadcast of the event will be available on the VMware Investor Relations website at http://ir.vmware.com. The replay of the webcast will be available for two months.

About VMware

VMware software powers the world’s complex digital infrastructure. The company’s cloud, app modernization, networking, security, and digital workspace offerings help customers deliver any application on any cloud across any device. Headquartered in Palo Alto, California, VMware is committed to being a force for good, from its breakthrough technology innovations to its global impact. For more information, please visit https://www.vmware.com/company.html.

Additional Information

VMware’s website is located at www.vmware.com, and its investor relations website is located at http://ir.vmware.com. VMware’s goal is to maintain the investor relations website as a portal through which investors can easily find or navigate to pertinent information about VMware, all of which is made available free of charge. The additional information includes: materials that VMware files with the SEC; announcements of investor conferences, speeches and events at which its executives talk about its products, services and competitive strategies; webcasts of its quarterly earnings calls, investor conferences and events (archives of which are also available for a limited time); additional information on its financial metrics, including reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures; press releases on quarterly earnings, product and service announcements, legal developments and international news; corporate governance information; other news, blogs and announcements that VMware may post from time to time that investors may find useful or interesting; and opportunities to sign up for email alerts and RSS feeds to have information pushed in real time.

VMware is a registered trademark or trademark of VMware, Inc. or its subsidiaries in the United States and other jurisdictions. All other marks and names mentioned herein may be trademarks of their respective organizations.

Use of Non-GAAP Financial Measures

Reconciliations of non-GAAP financial measures to VMware’s financial results as determined in accordance with GAAP are included at the end of this press release following the accompanying financial data. For a description of these non-GAAP financial measures, including the reasons management uses each measure, please see “About Non-GAAP Financial Measures.”

Forward-Looking Statements

This press release contains forward-looking statements including, among other things, statements regarding preliminary financial results for the first quarter of VMware’s fiscal year 2022 (“FY22 Q1”), including with respect to expectations for revenue, combined subscription and SaaS and license revenue, GAAP and non-GAAP operating margin and GAAP and non-GAAP net income per diluted share. These forward-looking statements are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors. VMware’s expectations about its quarterly results are based on preliminary information about FY22 Q1 and are subject to revision. Although the quarter is now completed, VMware is still completing its standard financial reporting closing procedures. Accordingly, as VMware completes its normal quarter-end closing and review processes, actual results could differ materially from its preliminary estimates. Factors that could cause VMware’s actual results for the FY22 Q1 to differ materially from those contemplated by these forward-looking statements include, but are not limited to: (1) quarter-end closing and review processes developments, such as changes in preliminary results due to inaccurate data or assumptions, unforeseen expenses, changes in estimates or judgments related to tax liabilities, potential goodwill impairments, potential litigation, bad debts or other contingencies, and facts or circumstances affecting the application of VMware’s critical accounting policies, including revenue recognition; (2) disruptions resulting from personnel changes; (3) the impact of the COVID-19 pandemic on our operations; (4) the continued risk of litigation and regulatory actions; (5) VMware’s relationship with Dell Technologies and Dell’s ability to control matters requiring stockholder approval, including the election of VMware’s board members and matters relating to Dell’s investment in VMware; and (6) risks associated with cyber-attacks, information security and data privacy. These forward-looking statements are made as of the date of this press release, are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including VMware’s most recent reports on Form 10-K and Form 10-Q and current reports on Form 8- K that we may file from time to time, which could cause actual results to vary from expectations. VMware assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release.

VMware, Inc.

PRELIMINARY RECONCILIATION OF GAAP TO NON-GAAP OPERATING MARGIN

(unaudited)

 

Three Months Ended

April 30, 2021

GAAP operating margin

 

18.7

%

Stock-based compensation

 

8.8

 

Intangible amortization

 

2.6

 

Acquisition, disposition and other items

 

0.7

 

Non-GAAP operating margin

 

30.8

%

 
 

VMware, Inc.

PRELIMINARY RECONCILIATION OF GAAP TO NON-GAAP NET INCOME PER DILUTED SHARE

(unaudited)

 

Three Months Ended

April 30, 2021

GAAP net income per diluted share

$

1.01

 

Stock-based compensation

 

0.62

 

Intangible amortization

 

0.18

 

Acquisition, disposition and other items

 

0.14

 

Tax adjustment

 

(0.19

)

Non-GAAP net income per diluted share

$

1.76

 

About Non-GAAP Financial Measures

To provide investors and others with additional information regarding VMware’s results, VMware has disclosed in this preliminary earnings release the following non-GAAP financial measures: non-GAAP operating margin and non-GAAP net income per diluted share. VMware has provided a reconciliation of each non-GAAP financial measure used in this preliminary earnings release to the most directly comparable GAAP financial measure. These non-GAAP financial measures differ from GAAP in that they exclude stock-based compensation, employer payroll taxes on employee stock transactions, amortization of acquired intangible assets, realignment charges, acquisition, disposition and other items, and discrete items that impacted our GAAP tax rate, each as discussed below. Our non-GAAP financial measures also reflect the application of our non-GAAP tax rate.

VMware’s management uses these non-GAAP financial measures to understand and compare operating results across accounting periods, for internal budgeting and forecasting purposes, for short- and long-term operating plans, to calculate bonus payments and to evaluate VMware’s financial performance, the performance of its individual functional groups and the ability of operations to generate cash. Management believes these non-GAAP financial measures reflect VMware’s ongoing business in a manner that allows for meaningful period-to-period comparisons and analysis of trends in VMware’s business, as they exclude charges and gains that are not reflective of ongoing operating results. Management also believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating VMware’s operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. Additionally, management believes information regarding free cash flow provides investors and others with an important perspective on the cash available to make strategic acquisitions and investments, to repurchase shares, to fund ongoing operations and to fund other capital expenditures.

Management believes these non-GAAP financial measures are useful to investors and others in assessing VMware’s operating performance due to the following factors:

  • Stock-based compensation. Stock-based compensation is generally fixed at the time the stock-based instrument is granted and amortized over a period of several years. Although stock-based compensation is an important aspect of the compensation of VMware’s employees and executives, the expense for the fair value of the stock-based instruments VMware utilizes may bear little resemblance to the actual value realized upon the vesting or future exercise of the related stock-based awards. Management believes it is useful to exclude stock-based compensation in order to better understand the long-term performance of VMware’s core business.
  • Employer payroll taxes on employee stock transactions. The amount of employer payroll taxes on stock-based compensation is dependent on VMware’s stock price and other factors that are beyond VMware’s control and do not correlate to the operation of the business.
  • Amortization of acquired intangible assets. A portion of the purchase price of VMware’s acquisitions is generally allocated to intangible assets, such as intellectual property, and is subject to amortization. However, VMware does not acquire businesses on a predictable cycle. Additionally, the amount of an acquisition’s purchase price allocated to intangible assets and the term of its related amortization can vary significantly and are unique to each acquisition. Therefore, VMware believes that the presentation of non-GAAP financial measures that adjust for the amortization of intangible assets provides investors and others with a consistent basis for comparison across accounting periods.
  • Realignment charges. Realignment charges include workforce reductions, asset impairments, losses on asset disposals and costs to exit facilities. VMware’s management believes it is useful to exclude these items, when significant, as they are not reflective of VMware’s core business and operating results.
  • Acquisition, disposition and other items. As VMware does not acquire or dispose of businesses on a predictable cycle and the terms of each transaction can vary significantly and are unique to each transaction, VMware believes it is useful to exclude acquisition, disposition and other items when looking for a consistent basis for comparison across accounting periods. These items include:

– Direct costs of acquisitions and dispositions, such as transaction and advisory fees.

– Costs associated with integrating acquired businesses.

– Accruals for the portion of merger consideration payable in installments that may be paid in cash or VMware stock, at the option of VMware.

– Gains or losses on investments in equity securities, whether realized or unrealized.

– Charges recognized for non-recoverable strategic investments or gains recognized on the disposition of strategic investments.

– Gains or losses on sale or disposal of distinct lines of business or product offerings, or transactions with features similar to discontinued operations, including recoveries or charges recognized to adjust the fair value of assets that qualify as “held for sale.”

  • Certain litigation and other contingencies. VMware, from time to time, may incur charges or benefits that are outside of the ordinary course of VMware’s business related to litigation and other contingencies. VMware believes it is useful to exclude such charges or benefits because it does not consider such amounts to be part of the ongoing operation of VMware’s business and because of the singular nature of the claims underlying such matters.
  • Tax adjustment. Non-GAAP financial information for the quarter is adjusted for a tax rate equal to VMware’s annual estimated tax rate on non-GAAP income. This rate is based on VMware’s estimated annual GAAP income tax rate forecast, adjusted to account for items excluded from GAAP income in calculating VMware’s non-GAAP income as well as significant tax adjustments. VMware’s estimated tax rate on non-GAAP income is determined annually and may be adjusted during the year to take into account events or trends that VMware management believes materially impact the estimated annual rate including, but not limited to, significant changes resulting from tax legislation, material changes in the geographic mix of revenue and expenses, changes to our corporate structure and other significant events. Due to the differences in the tax treatment of items excluded from non-GAAP earnings, as well as the methodology applied to VMware’s estimated annual tax rates as described above, the estimated tax rate on non-GAAP income may differ from the GAAP tax rate and from VMware’s actual tax liabilities.

The use of non-GAAP financial measures has certain limitations because they do not reflect all items of income and expense that affect VMware’s operations. Specifically, in the case of stock-based compensation, if VMware did not pay out a portion of its compensation in the form of stock-based compensation and related employer payroll taxes, the cash salary expense included in operating expenses would be higher, which would affect VMware’s cash position. VMware compensates for these limitations by reconciling the non-GAAP financial measures to the most comparable GAAP financial measures. These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP and should not be considered measures of VMware’s liquidity. Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited.

Management encourages investors and others to review VMware’s financial information in its entirety and not rely on a single financial measure.

Paul Ziots

VMware Investor Relations

[email protected]

650-427-3267

Michael Thacker

VMware Corporate PR

[email protected]

650-427-4454

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Data Management Security Technology Telecommunications Mobile/Wireless Software Networks

MEDIA:

Logo
Logo
Photo
Photo
Raghu Raghuram (Photo: Business Wire)

Proofpoint’s Voice of the CISO 2021 Report Reveals Two-Thirds of Global CISOs Feel Unprepared to Cope with a Cyberattack

58% of survey respondents consider human error their organization’s biggest cyber vulnerability as hybrid workforce presents new challenges for cybersecurity teams

SUNNYVALE, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Proofpoint, Inc. (NASDAQ: PFPT), a leading cybersecurity and compliance company, today released its inaugural 2021 Voice of the CISO report which explores key challenges facing chief information security officers (CISOs) after an unprecedented twelve months. Sixty-six percent of CISOs feel their organization is unprepared to handle a cyberattack and 58% consider human error to be their biggest cyber vulnerability, proving that the work-from-home model necessitated by the pandemic has tested CISOs like never before.

This year’s Voice of the CISO report examines global third-party survey responses from more than 1,400 CISOs at mid to large size organizations across different industries. Throughout the course of Q1 2021, one hundred CISOs were interviewed in each market across 14 countries: the U.S., Canada, the UK, France, Germany, Italy, Spain, Sweden, the Netherlands, UAE, Saudi Arabia (KSA), Australia, Japan, and Singapore.

The survey explores three key areas: the threat risk and types of cyber-attacks CISOs combat daily, the levels of employee and organizational preparedness to face them, and the impact of supporting a hybrid workforce as businesses prepare to re-open their corporate offices. It also covers the challenges CISOs face in their roles, position amongst the C-suite, and business expectations of their teams.

“Last year, cybersecurity teams around the world were challenged to enhance their security posture in this new and changing landscape, literally overnight. This required a balancing act between supporting remote work and avoiding business interruption, while securing those environments,” commented Lucia Milică, global resident CISO at Proofpoint. “With the future of work becoming increasingly flexible, this challenge now extends into next year and beyond. In addition to securing many more points of attack and educating users on long-term remote and hybrid work, CISOs must instill confidence among customers, internal stakeholders, and the market that such setups are workable indefinitely.”

Proofpoint’s Voice of the CISO 2021 report highlights general trends as well as regional differences amongst the global CISO community. Key global findings include:

  • CISOs are on high alert across a range of threats: faced with a relentless attack landscape, 64% of surveyed CISOs feel at risk of suffering a material cyberattack in the next 12 months. When asked about the types of attacks they expect to face, there was no clear answer, with diverse threats such as Business Email Compromise (34%), Cloud Account Compromise (O365 or G suite accounts being compromised, 33%), and insider threats (31%) topping the list. Despite dominating recent headlines, supply chain attacks came in fifth with 29% and ransomware seventh with 27%.

  • Organizational cyber preparedness is still a major concern: more than a year on into a pandemic that forever changed the threat landscape, 66% of CISOs feel their organization is unprepared to cope with a targeted cyberattack in 2021. Cyber risk is also on the rise: 53% of CISOs are more concerned about the repercussions of a cyberattack in 2021 than they were in 2020.

  • User awareness doesn’t always lead to behavioral change: while more than half of survey respondents believe employees understand their role in protecting their organization from cyber threats, 58% of global CISOs still consider human error to be their organization’s biggest cyber vulnerability. Global CISOs listed purposefully leaking data (criminal insider attack) and clicking malicious links or downloading compromised files as the most likely ways employees put their business at risk.

  • Long term hybrid work environments present a new challenge for CISOs: 58% of CISOs agree that remote working has made their organization more vulnerable to targeted cyberattacks, with three in five revealing they had seen an increase in targeted attacks in the last 12 months.

  • High risk, high reward likely to be a common cyber theme over the next two years: 63% of CISOs believe that cybercrime will become even more profitable for attackers, while 60% believe that it will become riskier for cybercriminals.

  • CISOs will adapt their cybersecurity strategy to stay ahead: Overall, the majority of global CISOs expect their cybersecurity budget to increase by 11% or more over the next two years, and two in three (65%) believe they will be able to better resist and recover from cyberattacks by 2023. Top three priorities across the board for global CISOs over the next two years are: enhancing core security controls (35%), supporting remote working (33%), as well as security awareness (32%) and security automation (32%).

  • 2020 elevated the CISO role, as well as the expectations from the business: 57% of global CISOs agree that expectations on their function are excessive. The perceived lack of support from the boardroom persists with only 25% of global CISOs strongly agreeing that their board see eye-to-eye with them on issues of cybersecurity.

“The ‘good enough’ approach of the past 12 months will simply not work in the long term: with businesses unlikely to ever return to pre-pandemic working practices, the mandate to strengthen cyber security defenses has never been more pressing,” said Ryan Kalember, executive vice president of Cybersecurity Strategy for Proofpoint. “CISOs hold a business-critical function, now more than ever. The findings from our report emphasize that CISOs need the tools to mitigate risk and develop a strategy that takes a people-centric approach to cybersecurity protection to address ever-changing conditions, like those experienced by organizations throughout the pandemic.”

To download the 2021 Voice of the CISO report, please visit:https://www.proofpoint.com/us/resources/white-papers/voice-of-the-ciso-report. For more information on Proofpoint’s unique approach to people-centric cybersecurity and compliance, please visit: https://www.proofpoint.com/us/why-proofpoint.

About Proofpoint, Inc.

Proofpoint, Inc. (NASDAQ: PFPT) is a leading cybersecurity and compliance company that protects organizations’ greatest assets and biggest risks: their people. With an integrated suite of cloud-based solutions, Proofpoint helps companies around the world stop targeted threats, safeguard their data, and make their users more resilient against cyber attacks. Leading organizations of all sizes, including more than half of the Fortune 1000, rely on Proofpoint for people-centric security and compliance solutions that mitigate their most critical risks across email, the cloud, social media, and the web. More information is available at www.proofpoint.com.

Connect with Proofpoint: Twitter | LinkedIn | Facebook | YouTube

Proofpoint is a registered trademark or tradename of Proofpoint, Inc. in the U.S. and/or other countries. All other trademarks contained herein are the property of their respective owners.

PROOFPOINT MEDIA CONTACT:

Kristy Campbell
Proofpoint, Inc.
(408) 850-4142
[email protected]



Outlook Therapeutics to Host Virtual Clinical Day on May 20, 2021

Live video webcast with Outlook Therapeutics’ management team and key opinion leaders on Thursday, May 20th from 11:00 AM – 1:00 PM ET

ISELIN, N.J., May 12, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it will host a Virtual Clinical Day for analysts and accredited institutional investors with live video webcast (details below) on Thursday, May 20, 2021 from 11:00 AM – 1:00 PM ET.

During the Virtual Clinical Day, Outlook Therapeutics will provide an overview of its lead program, ONS-5010 / LYTENAVA™ (bevacizumab-vikg), its investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), its ongoing Phase 3 study in wet AMD, NORSE TWO, and its plans for a potential commercial rollout.

Lawrence A. Kenyon, President, CEO and CFO of Outlook Therapeutics will host the event and will be joined by Outlook Therapeutics’ management team members, Terry Dagnon, Chief Operating Officer, and Jeff Evanson, Chief Commercial Officer.

Key opinion leaders will also join the management team to discuss Outlook Therapeutics’ current clinical program and strategy, as well as the market need for a responsibly priced, ophthalmic formulation of bevacizumab approved by the U.S. Food and Drug Administration (FDA):

  • Mark Humayun, MD, PhD, Medical Advisor to Outlook Therapeutics; Ophthalmologist, Engineer, Inventor; National Medal of Technology and Innovation awarded by President Barack Obama, 2016; Top 1% Ophthalmologists (U.S. News & World Report); Member, U.S. National Academics of Medicine and Engineering; Pyron Award, American Society of Retina Specialists; Past President, American Society of Retina Specialists; Co-inventor of Argus II, which offers functional sight to patients with complete retinal blindness
  • Firas M. Rahhal, MD, Senior Partner, Retina-Vitreous Associates Medical Group in Los Angeles and Associate Clinical Professor of Ophthalmology at the UCLA Geffen School of Medicine

Webcast Details

Interested participants and investors may dial into the event using (877) 407-9708 (domestic) or (201) 689-8259 (international), or can access the live video webcast and accompanying slide presentation on the Events page of the Investors section of the Outlook Therapeutics website, outlooktherapeutics.com. The webcast replay will be archived for 90 days following the event.

About ONS-5010 / LYTENAVA™ (bevacizumab-vikg)

ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet AMD and other retinal diseases. Because no currently approved ophthalmic formulations of bevacizumab are available, clinicians wishing to treat retinal patients with bevacizumab have had to use unapproved repackaged IV bevacizumab provided by compounding pharmacists, products that have known risks of contamination and inconsistent potency and availability. If approved, ONS-5010 will reduce the need for use of unapproved repackaged IV bevacizumab from compounding pharmacists for retinal disease.

ONS-5010 is a full-length, humanized anti-VEGF (Vascular Endothelial Growth Factor) recombinant monoclonal antibody (mAb) that inhibits VEGF and associated angiogenic activity. VEGF is a protein that promotes the growth of new abnormal blood vessels. With wet AMD, abnormally high levels of VEGF are secreted in the eye and lead to loss of vision. Anti-VEGF injection therapy blocks this growth. Since the advent of anti-VEGF therapy, it has become the standard-of-care treatment option within the retina community globally.

About Outlook Therapeutics, Inc.

Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010/LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD, diabetic macular edema and branch retinal vein occlusion. If ONS-5010 is approved, Outlook Therapeutics expects to commercialize it as the first and only FDA-approved ophthalmic formulation of bevacizumab for use in treating a range of retinal diseases in the United States, United Kingdom, Europe, Japan, China and other markets. Outlook Therapeutics expects to file ONS-5010 with the U.S. FDA as a new BLA under the PHSA 351(a) regulatory pathway, initially for wet AMD. For more information, please visit www.outlooktherapeutics.com.

CONTACTS:

Media Inquiries:

Harriet Ullman
Assistant Vice President
LaVoieHealthScience
T: 617-669-3082
[email protected]

Investor Inquiries:

Jenene Thomas
Chief Executive Officer
JTC Team, LLC
T: 833.475.8247
[email protected]

 



Superior Drilling Products, Inc. Revenue Increased 57% Sequentially to $2.4 million in First Quarter 2021

Superior Drilling Products, Inc. Revenue Increased 57% Sequentially to $2.4 million in First Quarter 2021

  •  First quarter revenue grew $0.9 million to $2.4 million over trailing fourth quarter as market steadily improves
  • U.S. market conditions strengthening and market share expanding driving revenue in North America up 74% over trailing quarter
  • Tool revenue grew 84% over the trailing quarter while Contract Services revenue was up 19%
  • Cost savings efforts and improved revenue resulted in positive cash generation from operations; ended quarter with $2.3 million of cash on hand
  • Restructured international team to build market opportunity while expanding relationships with major oil field service companies to deepen market reach

VERNAL, Utah–(BUSINESS WIRE)–
Superior Drilling Products, Inc. (NYSE American: SDPI) (“SDP” or the “Company”), a designer and manufacturer of drilling tool technologies, today reported financial results for the first quarter of 2021 ended March 31, 2021.

Troy Meier, Chairman and CEO, commented, “The pace of activity is encouraging as markets begin to recover. Demand for new Drill-N-Ream® well bore conditioning tools in North America continued through April as market conditions strengthen. We believe we are also continuing to gain market share in this depressed environment as more operators recognize both the production efficiencies gained and costs saved when using the DNR for their drilling operations. Drill bit refurbishment activity has increased as well during the quarter, with the growing number of drill rigs operating in the U.S.”

He added, “We are bringing back fabricators, advancing new drill bit development and we are making progress on broader marketing and servicing agreements with much larger entities that have the breadth to extend and deepen our market reach. While we are not expecting the market in the U.S. to return to pre-COVID levels, we believe that there is still plenty of room for improvement and more market penetration potential for the DNR. We have also restructured our international development team to improve returns on our investments in those markets while also advancing the agreements needed to gain market share.”

Mr. Meier concluded, “We are optimistic about the recovery supporting growth through 2021. More significantly, we are excited about the changes we are making in the organization and the relationships we are building that we expect to drive significant growth for the Company in the long-term.”

First Quarter 2021 Review ($ in thousands, except per share amounts) (See at “Definitions” the composition of product/service revenue categories.)

($ in thousands, except per share amounts) March 31,
2021
December 31,
2020
March 31,
2020
Change
Sequential
Change
Year/Year
North America

 

2,092

 

1,203

 

4,581

73.9

%

(54.3

)%

International

 

332

 

338

 

777

(1.7

)%

(57.2

)%

Total Revenue

$

2,425

$

1,541

$

5,358

57.3

%

(54.7

)%

Tool Sales/Rental

$

831

$

342

$

1,768

143.0

%

(53.0

)%

Other Related Tool Revenue

 

832

 

561

 

1,845

48.3

%

(54.9

)%

Tool Revenue

 

1,664

 

903

 

3,613

84.2

%

(54.0

)%

Contract Services

 

761

 

638

 

1,745

19.3

%

(56.4

)%

Total Revenue

$

2,425

$

1,541

$

5,358

57.3

%

(54.7

)%

Revenue increased sequentially $884 thousand, or 57%, over the trailing fourth quarter as market share and market conditions improved. The year-over-year comparison reflects the impact of the global pandemic on the oil & gas production industry. The market in North America is improving more rapidly than international markets. Revenue in North America increased 74% from increased tool sales, as well as higher royalty and repair fees. Contract Services revenue also improved sequentially reflecting increased drill bit refurbishment. International revenue was relatively unchanged from the trailing fourth quarter as the market recovery is lagging similar to the lag in decline this market had through 2020.

First Quarter 2021 Operating Costs

($ in thousands,except per share amounts) March 31,
2021
December 31,
2020
March 31,
2020
Change
Sequential
Change
Year/Year
Cost of revenue

$

1,176

 

$

821

 

$

2,315

 

43.2

%

(49.2

)%

As a percent of sales

 

48.5

%

 

53.3

%

 

43.2

%

Selling, general & administrative

$

1,516

 

$

1,483

 

$

2,018

 

2.2

%

(24.9

)%

As a percent of sales

 

62.5

%

 

96.2

%

 

37.7

%

Depreciation & amortization

$

690

 

$

682

 

$

761

 

1.2

%

(9.3

)%

Total operating expenses

$

3,381

 

$

2,986

 

$

5,093

 

13.2

%

(33.6

)%

Operating Income (loss)

$

(957

)

$

(1,445

)

$

265

 

NM

 

NM

 

As a % of sales

 

(39.5

)%

 

(93.8

)%

 

4.9

%

Other (expense) income including
income tax (expense)

$

(145

)

$

790

 

$

(67

)

NM

 

NM

 

Net income (loss)

$

(1,102

)

$

(655

)

$

198

 

NM

 

NM

 

Diluted earnings (loss) per share

$

(0.04

)

$

(0.03

)

$

0.01

 

NM

 

NM

 

Adjusted EBITDA(1)

$

(11

)

$

(494

)

$

1,221

 

NM

 

NM

 

(1) Adjusted EBITDA is a non-GAAP measure defined as earnings before interest, taxes, depreciation and amortization, non-cash stock compensation expense and unusual items. See the attached tables for important disclosures regarding SDP’s use of Adjusted EBITDA, as well as a reconciliation of net loss to Adjusted EBITDA.

Total operating expenses increased 13% over the trailing fourth quarter, while revenue increased 57% demonstrating the effect of cost reduction efforts and the operating leverage gained from higher volume.

Net loss for the quarter was $1.1 million compared with $0.7 million in the trailing fourth quarter which included a $0.9 million benefit from the government forgiveness of SBA debt. Compared with the trailing fourth quarter, Adjusted EBITDA(1) improved sequentially as a result of increased sales and operating leverage gained from higher volume.

The Company believes that when used in conjunction with measures prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), Adjusted EBITDA, which is a non-GAAP measure, helps in the understanding of its operating performance.

Balance Sheet and Liquidity

Cash at the end of the quarter was $2.3 million, up from $2.0 million at the end of 2020. Cash provided by operations in the first quarter of 2021 was $139 thousand. Long-term debt, including the current portion at March 31, 2021, was $3.0 million. The $4.2 million long-term financial obligation is related to the future minimum lease payments under the 15-year lease of the Company’s Vernal, Utah property.

Definitions and Composition of Product/Service Revenue:

Contract Services Revenue is comprised of drill bit and other repair and manufacturing services.

Other Related Tool Revenue is comprised of royalties and fleet maintenance fees.

Tool Sales/Rental revenue is comprised of revenue from either the sale of tools or tools rented to customers.

Tool Revenue is the sum of Other Related Tool Revenue and Tool Sales/Rental revenue.

Webcast and Conference Call

The Company will host a conference call and live webcast today at 10:00 am MT (12:00 pm ET) to review the results of the quarter and full year and discuss its corporate strategy and outlook. The discussion will be accompanied by a slide presentation that will be made available prior to the conference call on SDP’s website at www.sdpi.com/events. A question-and-answer session will follow the formal presentation.

The conference call can be accessed by calling (201) 689-8470. Alternatively, the webcast can be monitored at www.sdpi.com/events. A telephonic replay will be available from 1:00 p.m. MT (3:00 p.m. ET) the day of the teleconference until Wednesday, May 19, 2021. To listen to the archived call, please call (412) 317-6671 and enter conference ID number 13718357, or access the webcast replay at www.sdpi.com, where a transcript will be posted once available.

About Superior Drilling Products, Inc.

Superior Drilling Products, Inc. is an innovative, cutting-edge drilling tool technology company providing cost saving solutions that drive production efficiencies for the oil and natural gas drilling industry. The Company designs, manufactures, repairs and sells drilling tools. SDP drilling solutions include the patented Drill-N-Ream® well bore conditioning tool and the patented Strider oscillation system technology. In addition, SDP is a manufacturer and refurbisher of PDC (polycrystalline diamond compact) drill bits for a leading oil field service company. SDP operates a state-of-the-art drill tool fabrication facility, where it manufactures its solutions for the drilling industry, as well as customers’ custom products. The Company’s strategy for growth is to leverage its expertise in drill tool technology and innovative, precision machining in order to broaden its product offerings and solutions for the oil and gas industry.

Additional information about the Company can be found at: www.sdpi.com.

Safe Harbor Regarding Forward Looking Statements

This news release contains forward-looking statements and information that are subject to a number of risks and uncertainties, many of which are beyond our control. All statements, other than statements of historical fact included in this release, including, without limitations, the continued impact of COVID-19 on the business, the Company’s strategy, future operations, success at developing future tools, the Company’s effectiveness at executing its business strategy and plans, financial position, estimated revenue and losses, projected costs, prospects, plans and objectives of management, and ability to outperform are forward-looking statements. The use of words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project”, “forecast,” “should” or “plan, and similar expressions are intended to identify forward-looking statements, although not all forward -looking statements contain such identifying words. These statements reflect the beliefs and expectations of the Company and are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, the duration of the COVID-19 pandemic and related impact on the oil and natural gas industry, the effectiveness of success at expansion in the Middle East, options available for market channels in North America, the deferral of the commercialization of the Strider technology, the success of the Company’s business strategy and prospects for growth; the market success of the Company’s specialized tools, effectiveness of its sales efforts, its cash flow and liquidity; financial projections and actual operating results; the amount, nature and timing of capital expenditures; the availability and terms of capital; competition and government regulations; and general economic conditions. These and other factors could adversely affect the outcome and financial effects of the Company’s plans and described herein. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.

FINANCIAL TABLES FOLLOW.

 
Superior Drilling Products, Inc.
Consolidated Condensed Statements Of Operations
(unaudited)
 

For the Three Months

Ended March 31,

 

2021

 

 

 

2020

 

 
Revenue
North America

$

2,092,200

 

$

4,580,510

 

International

 

332,453

 

 

777,253

 

Total revenue

$

2,424,653

 

$

5,357,763

 

 
Operating cost and expenses
Cost of revenue

 

1,175,593

 

 

2,314,508

 

Selling, general, and administrative expenses

 

1,515,590

 

 

2,017,899

 

Depreciation and amortization expense

 

690,074

 

 

760,764

 

 
Total operating costs and expenses

 

3,381,257

 

 

5,093,171

 

 
Operating Income (loss)

 

(956,604

)

 

264,592

 

 
Other income (expense)
Interest income

 

48

 

 

4,688

 

Interest expense

 

(138,057

)

 

(177,258

)

Loss on Fixed Asset Impairment

 

 

 

(30,000

)

Gain (loss) on sale or disposition of assets

 

10,000

 

 

142,234

 

Total other expense

 

(128,009

)

 

(60,336

)

 
Income (loss) Before Income Taxes

$

(1,084,613

)

$

204,256

 

 
Income tax expense

 

(800

)

 

(6,210

)

Foreign Tax

 

(16,380

)

 

 

Net Income (loss)

$

(1,101,793

)

$

198,046

 

 
Basic income (loss) earnings per common share

$

(0.04

)

$

0.01

 

 
Basic weighted average common shares outstanding

 

25,762,342

 

 

25,418,126

 

 
Diluted income (loss) per common Share

$

(0.04

)

$

0.01

 

 
Diluted weighted average common shares outstanding

 

25,762,342

 

 

25,418,126

 

 

Superior Drilling Products, Inc.

Consolidated Condensed Balance Sheets

 
March 31, 2021 December 31, 2020
(unaudited)
Assets
Current assets:
Cash

$

2,262,251

 

$

1,961,441

 

Accounts receivable, net

1,601,837

 

1,345,622

 

Prepaid expenses

109,354

 

90,269

 

Inventories

996,083

 

1,020,008

 

Asset held for sale

 

40,000

 

Other current assets

42,751

 

40,620

 

 
Total current assets

5,012,276

 

4,497,960

 

 
Property, plant and equipment, net

7,211,648

 

7,535,098

 

Intangible assets, net

527,778

 

819,444

 

Right of use Asset (net of amortizaton)

$

65,624

 

$

99,831

 

Other noncurrent assets

84,115

 

87,490

 

Total assets

$

12,901,441

 

$

13,039,823

 

 
Liabilities and Owners’ Equity
Current liabilities:
Accounts payable

$

741,727

 

$

430,015

 

Accrued expenses

1,468,257

 

1,091,518

 

Accrued Income tax

122,826

 

106,446

 

Current portion of Operating Lease Liability

54,063

 

79,313

 

Current portion of Long-term Financial Obligation

59,420

 

61,691

 

Current portion of long-term debt, net of discounts

1,651,283

 

1,397,337

 

 
Total current liabilities

$

4,097,576

 

$

3,166,320

 

 
Operating long term liability

11,561

 

20,518

 

Long-term Financial Obligation

4,161,463

 

4,178,261

 

Long-term debt, less current portion, net of discounts

1,341,487

 

1,451,049

 

Total liabilities

$

9,612,087

 

$

8,816,148

 

 
Stockholders’ equity
Common stock (25,418,126 and 25,418,126)

25,762

 

25,762

 

Additional paid-in-capital

40,787,092

 

40,619,620

 

Accumulated deficit

(37,523,500

)

(36,421,707

)

Total stockholders’ equity

$

3,289,354

 

$

4,223,675

 

Total liabilities and shareholders’ equity

$

12,901,441

 

$

13,039,823

 

Superior Drilling Products, Inc.
Consolidated Condensed Statement of Cash Flows
(Unaudited)
 
March 31,
2021
March 31, 2020
Cash Flows From Operating Activities
Net Income (Loss)

$

(1,101,793

)

$

198,046

 

Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense

690,074

 

760,764

 

Share-based compensation expense

167,473

 

106,996

 

Loss (Gain) on sale or disposition of assets

(10,000

)

(142,234

)

Impairment on asset held for sale

 

30,000

 

Amortization of deferred loan cost

4,631

 

4,631

 

Changes in operating assets and liabilities:
Accounts receivable

(256,215

)

625,419

 

Inventories

(41,795

)

(303,122

)

Prepaid expenses and other noncurrent assets

(17,841

)

296,392

 

Accounts payable and accrued expenses

688,451

 

660,731

 

Income Tax expense

16,380

 

6,210

 

Other long-term liabilities

 

(61,421

)

Net Cash Provided By Operating Activities

139,364

 

2,182,412

 

 
Cash Flows From Investing Activities
Purchases of property, plant and equipment

(9,237

)

(37,850

)

Proceeds from sale of fixed assets

50,000

 

117,833

 

Net Cash Provided By Investing Activities

40,763

 

79,983

 

 
Cash Flows From Financing Activities
Principal payments on debt

(135,403

)

(975,440

)

Proceeds received from debt borrowings

 

72,520

 

Payments on Revolving Loan

(280,245

)

(39,461

)

Proceeds received from Revolving Loan

536,331

 

812,224

 

Debt issuance Costs

 

 

Net Cash Provided By (Used In) Financing Activities

120,683

 

(130,157

)

 
Net change in Cash

300,810

 

2,132,238

 

Cash at Beginning of Period

1,961,441

 

1,217,014

 

Cash at End of Period

$

2,262,251

 

$

3,349,252

 

 
Supplemental information:
Cash paid for interest

$

130,363

 

$

182,369

 

Non-cash payment of other liabilities by offsetting recovery of related-party note receivable

$

 

$

 

Inventory converted to property, plant and equipment

$

65,720

 

$

47,907

 

Long term debt paid with Sale of Plane

$

 

$

211,667

 

 

Superior Drilling Products, Inc.

Adjusted EBITDA(1) Reconciliation

(unaudited)

 
($, in thousands) Three Months Ended
March 31, 2021 March 31, 2020 December 31, 2020
 
GAAP net income

$

(1,101,793

)

$

198,046

 

$

(655,142

)

Add back:
Depreciation and amortization

 

690,074

 

 

760,764

 

 

681,998

 

Interest expense, net

 

138,009

 

 

172,570

 

 

125,068

 

Share-based compensation

 

167,473

 

 

106,996

 

 

180,730

 

Net non-cash compensation

 

88,200

 

 

88,200

 

 

88,200

 

Income tax expense

 

17,180

 

 

6,210

 

 

8,582

 

(Gain) Loss on disposition of assets

 

(10,000

)

 

(112,234

)

 

(891,600

)

Recovery of Related Party Note Receivable

 

 

 

 

 

 

Non-GAAP adjusted EBITDA(1)

$

(10,858

)

$

1,220,552

 

$

(494,164

)

 
GAAP Revenue

$

2,424,653

 

$

5,357,763

 

$

1,541,205

 

Non-GAAP Adjusted EBITDA Margin

 

(0.4

)%

 

22.8

%

 

(32.1

)%

(1) Adjusted EBITDA represents net income adjusted for income taxes, interest, depreciation and amortization and other items as noted in the reconciliation table. The Company believes Adjusted EBITDA is an important supplemental measure of operating performance and uses it to assess performance and inform operating decisions. However, Adjusted EBITDA is not a GAAP financial measure. The Company’s calculation of Adjusted EBITDA should not be used as a substitute for GAAP measures of performance, including net cash provided by operations, operating income and net income. The Company’s method of calculating Adjusted EBITDA may vary substantially from the methods used by other companies and investors are cautioned not to rely unduly on it.

For more information, contact investor relations:

Deborah K. Pawlowski, Kei Advisors LLC

(716) 843-3908, [email protected]

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Mining/Minerals Oil/Gas Manufacturing Energy Natural Resources Other Manufacturing

MEDIA:

Logo
Logo

MassRoots Issues Update on Planned Acquisition of Empire Services

MassRoots Issues Update on Planned Acquisition of Empire Services

Upon completion of the transaction, MassRoots expects it will be generating significant revenues and positive cash flows from operations

NORFOLK, Va.–(BUSINESS WIRE)–
MassRoots, Inc. (“MassRoots” or the “Company”) (OTCPink:MSRT) today issued the following update on its planned acquisition of Empire Services, Inc. (“Empire”).

With the assistance of MassRoots’ team, Empire has launched a new corporate website which will enable its more than 600 daily customers to easily view each location’s daily prices for a variety of metals. This is the first of many technology solutions the companies plan to launch aimed at growing Empire’s revenues, streamlining its operations and enhancing its customer experience.

Established in 2002, Empire operates 10 metal recycling facilities in Virginia and North Carolina, and expects to continue expanding its footprint in the coming quarters. It has historically generated higher profit margins when market prices for metal rise.

Empire has engaged an independent accounting firm to audit its financials in accordance with the standards established by the Public Company Accounting Oversight Board (“PCAOB”). Subject to the completion of the audit and other closing conditions, the companies expect to close the transaction by August 13, 2021.

About MassRoots

MassRoots, Inc. (OTC Pink: MSRT) is a leading media company focused on the regulated cannabis industry, with a significant following and traffic across its online and social media platforms. MassRoots has been covered by CNBC, CNN, Financial Times, Wall Street Journal, New York Times, Reuters, and the Associated Press. For more information on MassRoots, please visit MassRootsInvestors.com.

About Empire Services

Established in 2002, Empire Services, Inc. operates 10 metal recycling facilities in Virginia and North Carolina and expects to continue expanding its footprint in the coming quarters. Empire is headquartered in Virginia and has approximately 65 employees as of May 2021.

Forward-looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results could differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in our filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Isaac Dietrich

(303) 816-8070

[email protected]

KEYWORDS: United States North America Virginia

INDUSTRY KEYWORDS: Tobacco Specialty Alternative Medicine Mining/Minerals Health General Health Retail Natural Resources Online Retail

MEDIA:

Logo
Logo

Kopin To Present at the 16th Annual Needham Virtual Technology & Media Conference

Kopin To Present at the 16th Annual Needham Virtual Technology & Media Conference

WESTBOROUGH, Mass.–(BUSINESS WIRE)–
Kopin Corporation (NASDAQ: KOPN), a leading provider of innovative wearable computing technologies and solutions, announced today that Mr. Richard Sneider, Chief Financial Officer, will present at the 16th Annual Needham Virtual Technology & Media Conference on Monday, May 17th at 3:45PM ET.

A live Webcast of the event will be made available on the investor relations portion of Kopin’s website at https://www.kopin.com/investor-events/.

About Kopin

Kopin Corporation is a leading developer and provider of innovative display and optical technologies sold as critical components and subassemblies for defense, industrial and consumer products. Kopin’s technology portfolio includes ultra-small Active Matrix Liquid Crystal displays (AMLCD), Liquid Crystal on Silicon (LCOS) displays and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin’s website at www.kopin.com.

Richard Sneider, 508-870-5959

Treasurer and Chief Financial Officer

[email protected]

or

Market Street Partners

Elliot Ashkenazy, 415-445-3234

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Hardware Audio/Video Consumer Electronics Other Technology Technology

MEDIA: